Found this on the news today. Cant find too much info on it yet. Only press releases. Myostatin inhibitor?
About BYM338 (bimagrumab) and the Novartis commitment to research in muscle therapeutics
BYM338 (bimagrumab) is a novel, fully human monoclonal antibody developed to treat pathological...